GLUCAGON-GLP-1-GIP TRIPLE AGONIST COMPOUNDS

The present invention relates to compounds which have agonist activity at the glucagon, GIP and GLP-1 receptors, and to their use in the treatment of metabolic disorders.

Saved in:
Bibliographic Details
Main Authors HANSEN, Kate, JUST, Rasmus, ØSTERLUND, Torben, RIBER, Ditte, SHELTON, Anne Pernille Tofteng, JESSEN, Lene
Format Patent
LanguageEnglish
Published 25.11.2021
Subjects
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to compounds which have agonist activity at the glucagon, GIP and GLP-1 receptors, and to their use in the treatment of metabolic disorders.
Bibliography:Application Number: US202117388328